Welcome to our dedicated page for Zeta Global Holdings SEC filings (Ticker: ZETA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Zeta Global Holdings Corp. filings document the reporting and governance record of an operating company built around the Zeta Marketing Platform and AI-driven marketing cloud software. Form 8-K reports furnish quarterly and annual results, guidance updates, customer and platform metrics, cash-flow information, and Regulation FD materials tied to corporate announcements.
The filing record also covers proxy matters, board governance, executive compensation and shareholder voting. Other material-event disclosures address acquisition agreements, unregistered equity securities, capital-structure matters and financial reporting items connected to the company’s enterprise marketing platform business.
ZETA — Form 144 notice of proposed sale by an affiliate. A holder filed to sell up to 385,662 shares of Class A Common Stock, with an aggregate market value of $6,872,496.84. The intended broker is Merrill Lynch (200 Park Ave, New York, NY 10166), with an approximate sale date of 10/17/2025 on the NYSE. Proceeds from any sale would go to the selling holder, not the company.
The filing notes prior activity in the last three months: 34,229 shares of Class A Common Stock were sold on 09/23/2025 for $743,625.16 by Family Trust No C5. As context, 238,040,782 shares were outstanding, as listed in the notice.
The securities to be sold were acquired via estate planning transfers on 08/18/2021, from the settlor of the trust, with the donor’s acquisition date listed as 01/01/2015.
Zeta Global (ZETA): Form 144 notice of proposed sale. A holder filed to sell up to 330,568 shares of Class A Common Stock with an aggregate market value of $5,890,721.76. The filing lists an approximate sale date of 10/17/2025 on the NYSE through Merrill Lynch, 200 Park Ave, New York, NY 10166.
The shares were acquired on 08/18/2021 via estate planning transfers, with the donor’s acquisition date stated as 01/01/2015. As context, shares outstanding were 238,040,782.
The filing also reports sales in the prior three months: 34,229 shares of Class A Common Stock on 09/23/2025 for gross proceeds of $743,625.16. This notice reflects a potential secondary sale by the holder; it does not involve the company issuing new shares.
Zeta Global Holdings Corp. (ZETA) filed a Form 144 notifying a proposed sale of 165,000 Class A common shares through Merrill Lynch with an aggregate market value of $3,036,000. The filing lists 238,040,782 shares outstanding and an approximate sale date of 10/10/2025. The securities were acquired on 02/26/2021 via estate planning transfers from the settlor of the trust, with the donor having acquired the securities on 01/01/2015. The filer also reported a recent sale on 09/15/2025 of 16,125 shares for gross proceeds of $325,180.25. The notice includes the required representation that the seller does not possess undisclosed material adverse information.
Zeta Global Holdings Corp. director reported acquiring 1,258 shares of Class A common stock as restricted stock on 10/01/2025, recorded at $19.87 per share. The grant represents the quarterly retainer under the 2021 Incentive Award Plan.
The award vests 25% one year from grant, with the remaining 75% vesting in four equal quarterly installments beginning on the first anniversary. Following the grant, beneficial ownership was 272,951 shares direct and 607,165 shares indirect by spouse.
Zeta Global Holdings Corp. has agreed to acquire the enterprise business of Marigold Group, Inc., Campaign Monitor Europe UK Ltd. and Selligent Holdings Limited for up to $325 million, in a mix of cash, newly issued Class A shares and a seller note.
At closing, Zeta will pay $100 million in cash and deliver $100 million in newly issued Class A common stock. A seller note of up to $125 million is due within three months of closing, with up to $50 million in cash and up to $75 million in cash or additional Zeta shares at Zeta’s election.
The number of shares issued will be based on Zeta’s 30‑day volume‑weighted average price before closing or note maturity. Zeta plans to rely on private placement exemptions and has agreed to register the stock consideration for resale. The company also reaffirmed its guidance for the quarter and full year 2025 and announced a conference call to discuss the deal.
Zeta Global Holdings Corp. (ZETA) submitted a Form 144 notice reporting a proposed sale of 25,000 shares of Class A common stock through Merrill Lynch on the NYSE, with an approximate sale date of 10/02/2025 and an aggregate market value of $556,250. The shares were acquired on 04/03/2024 via estate planning transfers from the settlor of the trust and originate from securities the filer holds against a total outstanding Class A share count of 2,114,490. The filing also lists multiple recent sales by Southbeach Trust R6 totaling 82,823 shares sold across dates in July–September 2025, with gross proceeds reported for each sale. The notice includes the seller's representation that no undisclosed material adverse information is known.
Zeta Global Holdings Corp. (ZETA) filed a Form 144 notifying a proposed sale of 1,526,658 Class A common shares through Merrill Lynch on the NYSE, with an aggregate market value of $31,067,490.30 and an approximate sale date of 09/22/2025. The filing reports that these shares were acquired on 04/03/2024 via estate planning transfers from the settlor of the trust for whose account the securities are being offered.
The form also discloses a recent sale by a related family trust: 18,336 shares sold on 08/21/2025 for $332,651.95. The filer attests they are not aware of undisclosed material adverse information and provides broker details for the planned transaction.
Zeta Global Holdings Corp. (ZETA) filed a Form 144 disclosing a proposed sale of 686,726 shares of Class A common stock through Merrill Lynch (200 Park Ave, New York) with an aggregate market value of $13,974,874.10. The filing states the shares were acquired on 04/03/2024 via estate planning transfers from the settlor of the trust for whose account the sale is being made; the donor acquired the securities on 01/01/2015. The filing lists approximately 238,040,782 shares outstanding and an approximate sale date of 09/12/2025. It also discloses a related sale in the past three months: 97,429 shares sold on 08/18/2025 for $1,900,006.77. No additional financial performance or forward guidance is provided.
David A. Steinberg, Chief Executive Officer and director of Zeta Global Holdings Corp. (ZETA), reported multiple transactions dated 08/22/2025 on Form 4. The filing shows dispositions of 814,182 Class A shares held directly by ACI Investment Partners, LLC and 26,424 Class A shares disposed by spouse, each reported at $0 price under code G(1). An additional 66,661 Class A shares are listed (note indicates inclusion of shares purchased under an ESPP). The filing also reports dispositions of various Class B shares that convert one-for-one into Class A shares, with underlying Class A share totals shown for multiple entities (for example, 397,889 Class B by ACI resulting in 397,889 Class A underlying). Following the reported transactions, the filing discloses beneficial ownership balances for multiple holding vehicles, including 2,332,987 Class A shares held indirectly by ACI Investment Partners, LLC.
Zeta Global Holdings Corp. (ZETA) submitted a Form 144 disclosing a proposed sale of 52,366 Class A common shares through Merrill Lynch on the NYSE with an aggregate market value of $980,815.18. The filing lists total shares outstanding of 238,040,782, so the proposed sale equals a very small fraction of the float. The shares were reported as acquired on 04/03/2024 via estate planning transfers from the settlor of the trust. The notice also reports a recent sale on 08/07/2025 of 20,541 shares generating $430,128.54. The filer certifies no undisclosed material information; the filing contains routine disclosure of secondary sales by a trust and no operating or earnings data.